SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
SCHEDULE 13G
|
(Rule 13d-102)
|
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
|
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
|
PURSUANT TO RULE 13d-2(b)
|
(Amendment No. )1
|
Fusion Pharmaceuticals Inc.
|
(Name of Issuer)
|
Common Shares, no par value
|
(Title of Class of Securities)
|
36118A100
|
(CUSIP Number)
|
June 30, 2020
|
(Date of Event Which Requires Filing of this Statement)
|
1.
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Johnson & Johnson
EIN: 22-1024240
|
|||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
||
3.
|
SEC USE ONLY
|
|||
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5.
|
SOLE VOTING POWER
-0-
|
||
6.
|
SHARED VOTING POWER
3,759,634 *
|
|||
7.
|
SOLE DISPOSITIVE POWER
-0- |
|||
8.
|
SHARED DISPOSITIVE POWER
3,759,634 *
|
|||
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
3,759,634 *
|
|||
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
[ ] |
||
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.0% **
|
|||
12.
|
TYPE OF REPORTING PERSON
CO
|
1.
|
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Johnson & Johnson Innovation-JJDC, Inc.
EIN: 22-2007137
|
|||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ]
|
||
3.
|
SEC USE ONLY
|
|||
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5.
|
SOLE VOTING POWER
-0- |
||
6.
|
SHARED VOTING POWER
3,759,634 *
|
|||
7.
|
SOLE DISPOSITIVE POWER
-0-
|
|||
8.
|
SHARED DISPOSITIVE POWER
3,759,634 *
|
|||
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
3,759,634 *
|
|||
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
[ ] |
||
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.0% **
|
|||
12.
|
TYPE OF REPORTING PERSON
CO |
ITEM 1(a)
|
NAME OF ISSUER:
|
Fusion Pharmaceuticals Inc.
|
|
ITEM 1(b)
|
ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
|
270 Longwood Road South, Hamilton, Ontario, Canada, L8P 0A6
|
|
ITEM 2(a)
|
NAME OF PERSON FILING:
|
This statement is being filed by Johnson & Johnson, a New Jersey corporation (“J&J”), and Johnson & Johnson Innovation-JJDC, Inc., a New
Jersey corporation (“JJDC”) (together, the “Reporting Persons”). JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to
indirectly beneficially own the securities that are directly beneficially owned by JJDC. The Joint Filing Agreement between the Reporting Persons is attached hereto as Exhibit 1.
|
|
ITEM 2(b)
|
ADDRESS OF PRINCIPAL BUSINESS OFFICE:
|
J&J: One Johnson & Johnson Plaza, New Brunswick, NJ 08933
JJDC: 410 George Street, New Brunswick, NJ 08901
|
|
ITEM 2(c)
|
CITIZENSHIP:
|
J&J: New Jersey
|
|
JJDC: New Jersey
|
|
ITEM 2(d)
|
TITLE OF CLASS OF SECURITIES:
|
Common Shares, no par value (“Common Shares”)
|
|
ITEM 2(e)
|
CUSIP NUMBER:
|
36118A100
|
|
ITEM 3
|
STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B) OR (C):
|
Not applicable.
|
ITEM 4
|
OWNERSHIP:
|
|||
The information set forth in the cover pages of this Schedule 13G is incorporated herein by reference thereto.
|
||||
ITEM 5
|
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
|
|||
Not applicable.
|
||||
ITEM 6
|
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
|
|||
Not applicable.
|
||||
ITEM 7
|
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:
|
|||
Not applicable.
|
ITEM 8
|
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
|
Not applicable.
|
|
ITEM 9
|
NOTICE OF DISSOLUTION OF GROUP:
|
Not applicable.
|
|
ITEM 10
|
CERTIFICATION:
|
By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
JOHNSON & JOHNSON
|
|||
By:
|
/s/ Matthew Orlando
|
||
Name:
|
Matthew Orlando
|
||
Title:
|
Secretary
|
||
JOHNSON & JOHNSON INNOVATION-JJDC, INC.
|
|||
By:
|
/s/ Kevin Norman
|
||
Name:
|
Kevin Norman
|
||
Title:
|
Assistant Secretary
|
JOHNSON & JOHNSON
|
|||
By:
|
/s/ Matthew Orlando
|
||
Name:
|
Matthew Orlando
|
||
Title:
|
Secretary
|
||
JOHNSON & JOHNSON INNOVATION-JJDC, INC.
|
|||
By:
|
/s/ Kevin Norman
|
||
Name:
|
Kevin Norman
|
||
Title:
|
Assistant Secretary
|